SCHEMBL1990346

SCHEMBL1990346

COc1ccc(F)cc1-c1ccc(S(=O)(=O)c2ccccc2)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.49
PTGS2 P35354 5/20 0.48
NR3C1 P04150 3/20 0.47
PGR P06401 3/20 0.47
PTGS1 P23219 3/20 0.47
PTGES2 Q9H7Z7 1/20 0.43
BACE1 P56817 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NR3C2 P08235 1/20 0.41
AR P10275 1/20 0.41
KDM4E B2RXH2 2/20 0.41
FFAR4 Q5NUL3 1/20 0.40
ACLY P53396 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ABCC9 O60706 1/20 0.40
ABCC8 Q09428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1989553 0.88 HTR6 (0.51) HTR6PTGS2NR3C1PGRPTGS1
SCHEMBL1989829 0.85 ABCC9 (0.43) KDM4EACLYALDH1A1ABCC9ABCC8
SCHEMBL1990136 0.84 PTGDR2 (0.52) KMT2AABCC9ABCC8KCNJ11KCNJ8
SCHEMBL1988882 0.84 HTR6 (0.47) HTR6PTGS2NR3C1PGRPTGS1
SCHEMBL1989827 0.83 PTGDR2 (0.44) PTGS2NR3C1PGRKDM4EACLY
SCHEMBL1998315 0.82 NR3C1 (0.49) PTGS2NR3C1PGRPTGS1PTGES2
SCHEMBL1992954 0.81 POLB (0.44) PTGS2PTGS1ACLYNPSR1ABCC9
SCHEMBL1989828 0.81 PTGDR2 (0.40) NR3C1PGRABCC9ABCC8KCNJ11
SCHEMBL1989562 0.80 PTGS2 (0.45) HTR6PTGS2NR3C1PGRPTGS1
SCHEMBL10973897 0.79 AKR1B1 (0.50) HTR6ABCC9ABCC8KCNJ11KCNJ8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415394-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (GB) 2013-04-09 US disclosed
US-8349897-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2013-01-08 US disclosed
US-20120178814-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease LUKER TIMOTHY JON (GB) 2012-07-12 US disclosed
US-8008350-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2011-08-30 US disclosed
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease ASTRAZENECA AB (SE) 2011-06-23 US disclosed
EP-1937633-B1 BIPHENYLOXYACETIC ACID DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASE ASTRAZENECA AB (SE) 2010-08-04 EP disclosed
US-20090036535-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease ASTRAZENECA AB (SE) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178814-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD HTR6 211/4885PTGS2 1220/4885NR3C1 619/4885
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD HTR6 211/4885PTGS2 1220/4885NR3C1 619/4885
US-20090036535-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD HTR6 211/4885PTGS2 1220/4885NR3C1 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.